학술논문
Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial
Document Type
Article
Author
Source
In Diabetes Research and Clinical Practice April 2019 150:331-341
Subject
Language
ISSN
0168-8227